Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Total Current Liabilities (2021 - 2025)

Zymeworks' Total Current Liabilities history spans 3 years, with the latest figure at $72.8 million for Q3 2023.

  • For Q3 2023, Total Current Liabilities rose 26.24% year-over-year to $72.8 million; the TTM value through Sep 2023 reached $72.8 million, up 26.24%, while the annual FY2022 figure was $95.6 million, 33.08% up from the prior year.
  • Total Current Liabilities for Q3 2023 was $72.8 million at Zymeworks, down from $93.5 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $95.6 million in Q4 2022 and bottomed at $57.7 million in Q3 2022.
  • The 3-year median for Total Current Liabilities is $72.4 million (2021), against an average of $76.5 million.
  • The largest annual shift saw Total Current Liabilities surged 33.08% in 2022 before it increased 26.24% in 2023.
  • A 3-year view of Total Current Liabilities shows it stood at $71.9 million in 2021, then skyrocketed by 33.08% to $95.6 million in 2022, then fell by 23.82% to $72.8 million in 2023.
  • Per Business Quant, the three most recent readings for ZYME's Total Current Liabilities are $72.8 million (Q3 2023), $93.5 million (Q2 2023), and $67.3 million (Q1 2023).